Data completeness
0/8 — Limited
Drug data last refreshed 26m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PRO-BANTHINE (propantheline bromide) is an anticholinergic agent available as an injectable formulation, historically used to treat gastrointestinal and genitourinary disorders by reducing smooth muscle spasms and secretions. This pre-launch NDA product represents a reformulation or reintroduction of a legacy therapeutic class.
Pre-Launch
Pre-launch status indicates small, focused commercial team building; hiring likely concentrated in regulatory affairs, market access, and launch planning roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PRO-BANTHINE offers exposure to the full launch lifecycle in a focused, smaller team environment typical of legacy product reintroductions. Roles emphasize regulatory navigation, market repositioning, and efficient commercialization of a known therapeutic class rather than breakthrough innovation.
Regulatory Affairs SpecialistMarket Access Manager
Worked on PRO-BANTHINE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.